Deli Hong, PhD
Postdoctoral Fellow
Deli Hong, PhD, was a research fellow in the laboratory from 2019 to 2026. His postdoctoral research focused on identifying novel therapeutic targets for small cell lung cancer (SCLC) harboring loss-of-function NOTCH mutations using genetically engineered mouse models and CRISPR screens. During his postdoctoral training, he was awarded the Charles A. King Trust Fellowship (2022–2024). He is currently a Scientist II at Astellas Pharma in Cambridge, Massachusetts.